These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
131 related items for PubMed ID: 16328723
1. Dose-response relationship for fractionated irradiation in the treatment of spinal meningeal melanocytomas: a review of the literature. Rades D, Schild SE. J Neurooncol; 2006 May; 77(3):311-4. PubMed ID: 16328723 [Abstract] [Full Text] [Related]
2. Therapy of meningeal melanocytomas. Rades D, Schild SE, Tatagiba M, Molina HA, Alberti W. Cancer; 2004 Jun 01; 100(11):2442-7. PubMed ID: 15160350 [Abstract] [Full Text] [Related]
3. Defining the best available treatment for neurocytomas in children. Rades D, Schild SE, Fehlauer F. Cancer; 2004 Dec 01; 101(11):2629-32. PubMed ID: 15494975 [Abstract] [Full Text] [Related]
4. Well-differentiated neurocytoma: what is the best available treatment? Rades D, Fehlauer F, Lamszus K, Schild SE, Hagel C, Westphal M, Alberti W. Neuro Oncol; 2005 Jan 01; 7(1):77-83. PubMed ID: 15701284 [Abstract] [Full Text] [Related]
5. [The value of radiotherapy in treatment of meningeal melanocytoma]. Rades D, Tatagiba M, Brandis A, Dubben HH, Karstens JH. Strahlenther Onkol; 2002 Jun 01; 178(6):336-42. PubMed ID: 12122790 [Abstract] [Full Text] [Related]
6. Treatment recommendations for the various subgroups of neurocytomas. Rades D, Schild SE. J Neurooncol; 2006 May 01; 77(3):305-9. PubMed ID: 16575540 [Abstract] [Full Text] [Related]
7. The Role of Radiotherapy for Meningeal Melanocytomas - A 20 Year Update. Rades D, Zemskova O, Gliemroth J, Yu NY. In Vivo; 2024 May 01; 38(3):1220-1228. PubMed ID: 38688652 [Abstract] [Full Text] [Related]
8. Malignant transformation of spinal meningeal melanocytoma. Case report and review of the literature. Wang F, Li X, Chen L, Pu X. J Neurosurg Spine; 2007 May 01; 6(5):451-4. PubMed ID: 17542513 [Abstract] [Full Text] [Related]
9. Local control in sinonasal malignant melanoma: Comparing conventional to hypofractionated radiotherapy. Lansu J, Klop WM, Heemsbergen W, Navran A, Al-Mamgani A, Langendijk JA, Kaanders JH, Terhaard C, Karakullukcu B, Hamming-Vrieze O. Head Neck; 2018 Jan 01; 40(1):86-93. PubMed ID: 29044881 [Abstract] [Full Text] [Related]
10. Therapeutic options for meningeal melanocytoma. Case report. Rades D, Heidenreich F, Tatagiba M, Brandis A, Karstens JH. J Neurosurg; 2001 Oct 01; 95(2 Suppl):225-31. PubMed ID: 11599841 [Abstract] [Full Text] [Related]
11. Spinal meningeal melanocytomas: clinical manifestations, radiological and pathological characteristics, and surgical outcomes. Yang C, Fang J, Li G, Jia W, Liu H, Qi W, Xu Y. J Neurooncol; 2016 Apr 01; 127(2):279-86. PubMed ID: 26940907 [Abstract] [Full Text] [Related]
12. A higher radiotherapy dose is associated with more durable palliation and longer survival in patients with metastatic melanoma. Olivier KR, Schild SE, Morris CG, Brown PD, Markovic SN. Cancer; 2007 Oct 15; 110(8):1791-5. PubMed ID: 17721993 [Abstract] [Full Text] [Related]
13. Radio(chemo)therapy plus resection versus radio(chemo)therapy alone for the treatment of stage III esophageal cancer. Rades D, Schulte R, Yekebas EF, Homann N, Schild SE, Dunst J. Strahlenther Onkol; 2007 Jan 15; 183(1):10-6. PubMed ID: 17225940 [Abstract] [Full Text] [Related]
14. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study. Valentini V, Morganti AG, Gambacorta MA, Mohiuddin M, Doglietto GB, Coco C, De Paoli A, Rossi C, Di Russo A, Valvo F, Bolzicco G, Dalla Palma M, Study Group for Therapies of Rectal Malignancies (STORM). Int J Radiat Oncol Biol Phys; 2006 Mar 15; 64(4):1129-39. PubMed ID: 16414206 [Abstract] [Full Text] [Related]
16. Definitive radiotherapy for meningeal brainstem melanocytoma: a case report. Fernandez C, Hoeltzel G, Werner-Wasik M, Kenyon LC, Shi W. Br J Neurosurg; 2023 Oct 15; 37(5):1307-1310. PubMed ID: 33356599 [Abstract] [Full Text] [Related]
17. A multi-institutional retrospective analysis of external radiotherapy for mucosal melanoma of the head and neck in Northern Japan. Wada H, Nemoto K, Ogawa Y, Hareyama M, Yoshida H, Takamura A, Ohmori K, Hamamoto Y, Sugita T, Saitoh M, Yamada S. Int J Radiat Oncol Biol Phys; 2004 Jun 01; 59(2):495-500. PubMed ID: 15145168 [Abstract] [Full Text] [Related]
18. Long-term outcomes of fractionated stereotactic radiotherapy for intracranial skull base benign meningiomas in single institution. Onodera S, Aoyama H, Katoh N, Taguchi H, Yasuda K, Yoshida D, Surtherland K, Suzuki R, Ishikawa M, Gerard B, Terasaka S, Shirato H. Jpn J Clin Oncol; 2011 Apr 01; 41(4):462-8. PubMed ID: 21177777 [Abstract] [Full Text] [Related]
19. Evaluation of five radiation schedules and prognostic factors for metastatic spinal cord compression. Rades D, Stalpers LJ, Veninga T, Schulte R, Hoskin PJ, Obralic N, Bajrovic A, Rudat V, Schwarz R, Hulshof MC, Poortmans P, Schild SE. J Clin Oncol; 2005 May 20; 23(15):3366-75. PubMed ID: 15908648 [Abstract] [Full Text] [Related]
20. Value of postoperative stereotactic radiosurgery and conventional radiotherapy for incompletely resected typical neurocytomas. Rades D, Schild SE. Cancer; 2006 Mar 01; 106(5):1140-3. PubMed ID: 16400638 [Abstract] [Full Text] [Related] Page: [Next] [New Search]